{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:52:12Z","timestamp":1792183932629,"version":"4.4.0"},"reference-count":61,"publisher":"Informa UK Limited","issue":"18","license":[{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016827","name":"Deciphera Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,7,27]]},"DOI":"10.1080\/14796694.2025.2520744","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T01:56:05Z","timestamp":1750643765000},"page":"2385-2400","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review"],"prefix":"10.1080","volume":"21","author":[{"given":"Michiel","family":"van de Sande","sequence":"first","affiliation":[{"name":"Leiden University Medical Center","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[{"name":"Centre L\u00e9on B\u00e9rard","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tap","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Lee","sequence":"additional","affiliation":[{"name":"Costello Medical","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Costello Medical","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steph","family":"Beaver","sequence":"additional","affiliation":[{"name":"Costello Medical","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3998-3417","authenticated-orcid":false,"given":"Brooke","family":"Harrow","sequence":"additional","affiliation":[{"name":"Deciphera Pharmaceuticals","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Zeringo","sequence":"additional","affiliation":[{"name":"Deciphera Pharmaceuticals","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bernthal","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,22]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31802b86f8"},{"issue":"3","key":"e_1_3_7_4_1","first-page":"547","article-title":"Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis","volume":"29","author":"Molena B","year":"2011","unstructured":"Molena B, Sfriso P, Oliviero F, et al. Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis. Clin Exp Rheumatol. 2011 May;29(3):547\u2013550.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507321103"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102491"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2016.11.002"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.03.008"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01820-6"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2024.2373687"},{"key":"e_1_3_7_11_1","unstructured":"Sankyo D. Pexidartinib (TURALIO) prescribing information 2023. [2025 Feb 28]. Available from: https:\/\/daiichisankyo.us\/prescribing-information-portlet\/getPIContent?productName=Turalio&inline=true"},{"key":"e_1_3_7_12_1","unstructured":"South Korea Ministry of Food and Drug Safety. Drug approval report 2021. 2021 [cited 2025 Feb 28]. Available from: https:\/\/www.mfds.go.kr\/eng\/brd\/m_19\/view.do?seq=70437&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1"},{"key":"e_1_3_7_13_1","unstructured":"Deciphera. ROMVIMZA (vimseltinib) US prescribing information 2025. [2025 Feb 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/219304s000lbl.pdf"},{"key":"e_1_3_7_14_1","unstructured":"European medicines agency. Turalio: Assessment Report; 2020."},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00885-7"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30764-0"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.2196\/ijmr.9325"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.075"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.038"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fas.2019.08.014"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.52965\/001c.39644"},{"key":"e_1_3_7_22_1","volume-title":"Connective Tissue Oncology Society (CTOS) Annual Meeting","author":"Dai D","year":"2022","unstructured":"Dai D, Lin F, Pan I, et al. Characteristics of patients receiving pexidartinibin the real-world setting: a cross-sectional survey. In: Connective Tissue Oncology Society (CTOS) Annual Meeting; Vancouver, Canada; 2022."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.22038\/abjs.2021.53750.2676"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160816"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.100B7.BJJ-2017-0867.R3"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-014-2852-5"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.knee.2017.04.019"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2021.10.001"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646929"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/os.13707"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-23-00047"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2017.1361126"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2020.08.030"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00097"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.900010"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.06.028"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1694736"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20230207-01"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2007"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01883-5"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad011"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-016-3208-1"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu230"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.101B3.BJJ-2018-0804.R1"},{"key":"e_1_3_7_45_1","volume-title":"Connective Tissue Oncology Society (CTOS) Annual Meeting","author":"Xu H","year":"2022","unstructured":"Xu H, Li B, Luo Y, et al. Preliminary phase 1b results of ABSK021 for advanced tenosynovial giant cell tumor: significant antitumor activity and favourable safety profile. In: Connective Tissue Oncology Society (CTOS) Annual Meeting; Vancouver, Canada; 2022."},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.3881\/j.issn.1000-503X.2015.02.017"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/os.13179"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0014.4136"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2008-0772"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26991"},{"key":"e_1_3_7_51_1","unstructured":"PROMIS. [cited 2024 Jul 11]. Available from: https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis"},{"key":"e_1_3_7_52_1","unstructured":"Meaningful change for PROMIS\u00ae. [cited 2024 Jul 11]. Available from: https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis\/meaningful-change"},{"key":"e_1_3_7_53_1","volume-title":"SF-12: how to score the SF-12 physical and mental health summary scales","author":"Ware JE","year":"1995","unstructured":"Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. Second Edition ed. Boston, MA: The Health Institute, New England Medical Center; 1995."},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02650-y"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.11.001"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.107953"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recot.2019.12.001"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7768764"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.01.004"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.119.BJR-2022-0054.R1"},{"key":"e_1_3_7_61_1","unstructured":"Pimicotinib significantly improved outcomes for patients with tenosynovial giant cell tumor in a global phase III. Trial: PR Newswire; 2024. Available from: https:\/\/www.prnewswire.com\/news-releases\/pimicotinib-significantly-improved-outcomes-for-patients-with-tenosynovial-giant-cell-tumor-in-a-global-phase-iii-trial-302301539.html"},{"key":"e_1_3_7_62_1","unstructured":"ClinicalTrials.gov. Study of emactuzumab for tenosynovial giant cell tumor (TGCT) (TANGENT) (NCT05417789) 2024 [08\/25\/2024]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05417789"},{"key":"e_1_3_7_63_1","unstructured":"Clinical study of HMPL-653 in treatment of advanced malignant solid tumors and TGCT (NCT05277454) 2022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05277454"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2520744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T14:00:17Z","timestamp":1754402417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2520744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":61,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,7,27]]}},"alternative-id":["10.1080\/14796694.2025.2520744"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2520744","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}